Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 201592, 11 pages
Research Article

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

1Department of Psychiatry, Shimane University School of Medicine, Izumo, Japan
2Research Institute of Traditional Asian Medicine, Kinki University, Higashi-Osaka, Japan
3Center for Advance Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
4Psychiatry & Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
5Psychiatry, Kanazawa University School of Medicine, Kanazawa, Japan
6Psychiatry, Chiba University School of Medicine, Chiba, Japan
7Psychiatry, Ehime University School of Medicine, Matsuyama, Japan
8Medical Center for Translational Research, Osaka University Hospital, Suita, Japan
9Psychiatry, Takeda General Hospital, Fukushima, Japan
10Psychiatry, Matsue Aoba Hospital, Matsue, Japan

Received 18 November 2014; Accepted 16 March 2015

Academic Editor: Yuping Tang

Copyright © 2015 Tsuyoshi Miyaoka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Kazunari Yoshida, Takefumi Suzuki, and Hiroyuki Uchida, “Psychopharmacology in Japan,” Journal of Clinical Psychopharmacology, pp. 1, 2018. View at Publisher · View at Google Scholar
  • Justin Faden, and Leslie Citrome, “Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment,” Expert Opinion on Pharmacotherapy, vol. 20, no. 1, pp. 11–24, 2018. View at Publisher · View at Google Scholar